Literature DB >> 29411411

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

S Ballou1, W Hirsch1, P Singh1, V Rangan1, J Nee1, J Iturrino1, T Sommers1, J Zubiago1, N Sengupta2, A Bollom1, M Jones3, A C Moss1, S N Flier1, A S Cheifetz1, A Lembo1.   

Abstract

BACKGROUND: Despite advances in treatment, patients with inflammatory bowel disease (IBD) frequently require emergency department (ED) visits and hospitalisations. AIMS: To analyse trends in ED visits and subsequent hospitalisations for IBD in the United States (US).
METHODS: Data were analysed from the Nationwide Emergency Department Sample (NEDS) years 2006-2014. The NEDS is the largest all-payer ED database in the US, weighted to represent 135 million visits/year. IBD was identified using ICD-9 codes for Crohn's disease (CD) or ulcerative colitis (UC). Surgeries were identified using procedure codes.
RESULTS: The frequency of IBD-ED visits increased 51.8%, from 90 846 visits in 2006 to 137 946 in 2014, which was statistically significant in linear regression. For comparison, all-case ED use between 2006 and 2014 increased 14.8%. In-patient hospitalisations from the ED decreased 12.1% for IBD (from 64.7% rate of hospitalisation from the ED in 2006 to 52.6% in 2014), with a UC:CD ratio of 1.2:1 in 2006 and 1.3:1 in 2014. Chi-square analysis revealed that this was a significant decrease. Surgery rates also showed a statistically significant decrease. The mean ED charge per patient rose 102.5% and the aggregate national cost of IBD-ED visits increased 207.5%. CD accounted for over twice as many visits as UC in both years. UC, age, male gender, highest income quartile, private insurance, Medicaid/Medicare, and tobacco use were associated with in-patient admissions.
CONCLUSIONS: The number of ED visits due to IBD and associated charges have continued to rise, while the rates of in-patient hospitalisations referred from the ED and surgeries have decreased.
© 2018 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29411411      PMCID: PMC5927595          DOI: 10.1111/apt.14551

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  34 in total

1.  Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA.

Authors:  Mahesh Gajendran; Chandraprakash Umapathy; Priyadarshini Loganathan; Jana G Hashash; Ioannis E Koutroubakis; David G Binion
Journal:  Dig Dis Sci       Date:  2015-09-30       Impact factor: 3.199

2.  National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States.

Authors:  Geoffrey C Nguyen; Christopher A Chong; Rachel Y Chong
Journal:  J Crohns Colitis       Date:  2013-09-24       Impact factor: 9.071

3.  Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience.

Authors:  K T Park; Aaron Sin; May Wu; Dorsey Bass; Jay Bhattacharya
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

4.  Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study.

Authors:  Zoann Nugent; Harminder Singh; Laura E Targownik; Trevor Strome; Carolyn Snider; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2016-12       Impact factor: 5.325

5.  Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis.

Authors:  P C Lunney; V C Kariyawasam; R R Wang; K L Middleton; T Huang; C P Selinger; J M Andrews; P H Katelaris; R W L Leong
Journal:  Aliment Pharmacol Ther       Date:  2015-05-12       Impact factor: 8.171

6.  Time trends of physician visits for Crohn's disease and ulcerative colitis in the United States, 1960-2006.

Authors:  Amnon Sonnenberg; Joanne Chang
Journal:  Inflamm Bowel Dis       Date:  2008-02       Impact factor: 5.325

7.  Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.

Authors:  Michael D Kappelman; Sheryl L Rifas-Shiman; Carol Q Porter; Daniel A Ollendorf; Robert S Sandler; Joseph A Galanko; Jonathan A Finkelstein
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

8.  Report: economic implications of inflammatory bowel disease and its management.

Authors:  Foram Mehta
Journal:  Am J Manag Care       Date:  2016-03       Impact factor: 2.229

9.  Trends in ambulatory and emergency room visits for inflammatory bowel diseases in the United States: 1994-2005.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian; David G Binion
Journal:  Am J Gastroenterol       Date:  2009-10-06       Impact factor: 10.864

Review 10.  A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease.

Authors:  Nadia Pillai; Mark Dusheiko; Bernard Burnand; Valérie Pittet
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

View more
  10 in total

1.  Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease.

Authors:  Kaleb Bogale; Parth Maheshwari; Mitchell Kang; Venkata Subhash Gorrepati; Shannon Dalessio; Vonn Walter; August Stuart; Walter Koltun; Nana Bernasko; Andrew Tinsley; Emmanuelle D Williams; Kofi Clarke; Matthew D Coates
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

Review 2.  Therapeutic strategies in Crohn's disease in an emergency surgical setting.

Authors:  Maria Michela Chiarello; Gilda Pepe; Valeria Fico; Valentina Bianchi; Giuseppe Tropeano; Gaia Altieri; Giuseppe Brisinda
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

3.  Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005-2013.

Authors:  Mustafa Shawihdi; Susanna Dodd; Constantinos Kallis; Pete Dixon; Ruth Grainger; Stuart Bloom; Fraser Cummings; Mike Pearson; Keith Bodger
Journal:  Aliment Pharmacol Ther       Date:  2019-05-28       Impact factor: 8.171

4.  Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD.

Authors:  Gil Berkovitch; Shlomi Cohen; Ronit Lubetzky; Dana Singer; Anat Yerushalmy-Feler
Journal:  BMC Pediatr       Date:  2021-02-04       Impact factor: 2.125

5.  Gastroenterologist Consultation Is Uncommon but Associated with Improved Care Among IBD Patients Presenting to Emergency Departments in Winnipeg Hospitals.

Authors:  Charles N Bernstein; Elise Crocker; Zoann Nugent; Paramvir Virdi; Harminder Singh; Laura E Targownik
Journal:  J Can Assoc Gastroenterol       Date:  2020-02-17

6.  Trends in US emergency department visits and subsequent hospital admission among patients with inflammatory bowel disease presenting with abdominal pain: a real-world study from a national emergency department sample database.

Authors:  Zhijie Ding; Aarti Patel; James Izanec; Christopher D Pericone; Jennifer H Lin; Christopher W Baugh
Journal:  J Mark Access Health Policy       Date:  2021-04-19

7.  Point-of-Care Ultrasound Diagnosis of a Crohn's Disease-Related Intraabdominal Abscess in the Emergency Department.

Authors:  Kevin Rivera; Gabriel Cabrera; Eric J Kalivoda
Journal:  Cureus       Date:  2021-04-04

8.  Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019.

Authors:  Yang Zhang; Jiali Liu; Xiao Han; Hui Jiang; Liming Zhang; Juncong Hu; Lei Shi; Junxiang Li
Journal:  Front Public Health       Date:  2022-09-07

9.  Development of a Global Rating Scale for Inflammatory Bowel Disease.

Authors:  Alain Bitton; Katharine S Devitt; Brian Bressler; Joan Heatherington; Vipul Jairath; Jennifer Jones; Paul Moayyedi; Adam V Weizman; Catherine Dubé; Donald MacIntosh; Geoffrey C Nguyen
Journal:  J Can Assoc Gastroenterol       Date:  2019-06-11

10.  Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes.

Authors:  Sofia Nene; Lorant Gonczi; Zsuzsanna Kurti; Isabelle Morin; Kelly Chavez; Christine Verdon; Jason Reinglas; Rita Kohen; Talat Bessissow; Waqqas Afif; Gary Wild; Ernest Seidman; Alain Bitton; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2020-02-21       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.